ketoprofen has been researched along with Triple Negative Breast Neoplasms in 2 studies
Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
Excerpt | Relevance | Reference |
---|---|---|
"Ketoprofen is a Non-steroidal anti-inflammatory drug (NSAID) with anti-tumor properties." | 1.91 | Ketoprofen suppresses triple negative breast cancer cell growth by inducing apoptosis and inhibiting autophagy. ( Ahmad, I; Awadh, SA; Hamad, DA; Hameed, NM; Hussam, F; Kadhim, MM; Mustafa, YF; Naser, RH; Parra, RMR; Patra, I, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Patra, I | 1 |
Naser, RH | 1 |
Hussam, F | 1 |
Hameed, NM | 1 |
Kadhim, MM | 1 |
Ahmad, I | 1 |
Awadh, SA | 1 |
Hamad, DA | 1 |
Parra, RMR | 1 |
Mustafa, YF | 1 |
Ma, ZY | 1 |
Song, XQ | 1 |
Hu, JJ | 1 |
Wang, DB | 1 |
Ding, XJ | 1 |
Liu, RP | 1 |
Dai, ML | 1 |
Meng, FY | 1 |
Xu, JY | 1 |
2 other studies available for ketoprofen and Triple Negative Breast Neoplasms
Article | Year |
---|---|
Ketoprofen suppresses triple negative breast cancer cell growth by inducing apoptosis and inhibiting autophagy.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Humans; Janus Kinases; Ketoprofen; Signa | 2023 |
Ketoplatin in triple-negative breast cancer cells MDA-MB-231: High efficacy and low toxicity, and positive impact on inflammatory microenvironment.
Topics: A549 Cells; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cisplatin; Epit | 2021 |